Atovaquone-proguanil for recrudescentPlasmodium falciparumin Vietnam (Q39022879)

8 September 2017

Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam (English)

1 reference

8 September 2017

Atovaquone-proguanil for recrudescentPlasmodium falciparumin Vietnam (English)

1 reference

https://api.crossref.org/works/10.1179/000349803225001427

14 March 2024

main subject

Plasmodium falciparum

0 references

Vietnam

0 references

author name string

P. T. Giao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511555

14 March 2024

P. J. De Vries

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511555

14 March 2024

L. Q. Hung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511555

14 March 2024

T. Q. Binh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511555

14 March 2024

N. V. Nam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511555

14 March 2024

P. A. Kager

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511555

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14511555

14 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 September 2017

http://www.tandfonline.com/doi/pdf/10.1179/000349803225001427

1 reference

https://api.crossref.org/works/10.1179/000349803225001427

Annals of Tropical Medicine and Parasitology

14 March 2024

published in

1 reference

8 September 2017

97

1 reference

8 September 2017

6

1 reference

8 September 2017

575-580

1 reference

Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines

8 September 2017

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Inactivation of artemisinin by thalassemic erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Two patients with falciparum malaria and poor in vivo responses to artesunate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Atovaquone and proguanil for Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Viet Nam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Antimalarial drug resistance and combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349803225001427

Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy?

21 January 2018

6

1 reference

https://api.crossref.org/works/10.1179/000349803225001427

Drugs under Experimental and Clinical Research

14 March 2024

7

17

427

Hudson A. T.

1991

1 reference

https://api.crossref.org/works/10.1179/000349803225001427

Bulletin of the World Health Organization

14 March 2024

8

80

660

Hung L. Q.

2002

1 reference

https://api.crossref.org/works/10.1179/000349803225001427

Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group

14 March 2024

10

1 reference

https://api.crossref.org/works/10.1179/000349803225001427

Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1179/000349803225001427

A mechanism for the synergistic antimalarial action of atovaquone and proguanil

14 March 2024

15

1 reference

https://api.crossref.org/works/10.1179/000349803225001427

14 March 2024

Identifiers

1 reference

8 September 2017

1 reference